|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
+0.65% | -29.32% |
| 14/17/14 | Vernalis : AGM Statement | PU |
| 14/17/14 | Vernalis PLC: AGM Statement | MW |
| 13/17/13 | Vernalis : enters into research collaboration with Daiichi Sankyo | PU |
| 13/17/13 | Vernalis : + Daiichi Sankyo Enter Collaboration | MW |
| 06/17/06 | Vernalis : and Servier Achieve Research Milestone in Third Oncology Collaboration | PU |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Davis
BRD | Director/Board Member | 65 | 05/12/2022 |
Octavio Espinoza
BRD | Director/Board Member | 56 | 01/11/2022 |
Andrew Reardon
BRD | Director/Board Member | 52 | 01/11/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.65% | - | - | 0 | ||
| -2.49% | -3.76% | +50.31% | +62.10% | 6.37TCr | ||
| -0.63% | -2.91% | +6.20% | +89.22% | 5.86TCr | ||
| -2.37% | -2.22% | +22.87% | +82.31% | 5.42TCr | ||
| -2.19% | -6.15% | +11.92% | +108.08% | 4.47TCr | ||
| -1.89% | -7.28% | +13.22% | +19.74% | 4.05TCr | ||
| -0.93% | -0.47% | +19.73% | +43.75% | 3.63TCr | ||
| +1.11% | -6.44% | +130.68% | +641.83% | 3.49TCr | ||
| -0.80% | +0.61% | +77.26% | +56.26% | 3.23TCr | ||
| -2.17% | +16.65% | -29.21% | +474.05% | 3.1TCr | ||
| Average | -1.24% | -1.22% | +33.67% | +175.26% | 4TCr | |
| Weighted average by Cap. | -1.48% | -1.85% | +32.16% | +150.90% |
- Stock Market
- Stocks
- VER Stock
Select your edition
All financial news and data tailored to specific country editions
















